1. Wang, Kai, Zhang, Hao-Nan, Du, Yong. 2023. MEX3C induces cognitive impairment in mice through autophagy inhibition. In Brain and behavior, 13, e3245. doi:10.1002/brb3.3245. https://pubmed.ncbi.nlm.nih.gov/37652868/
2. Guo, Jinhui, Zhao, Jie, Xu, Qiuran, Huang, Dongsheng. 2023. MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib. In BMC cancer, 23, 967. doi:10.1186/s12885-023-11320-4. https://pubmed.ncbi.nlm.nih.gov/37828435/
3. He, Zelai, Zhang, Huijun, Xiao, Haibo, Sun, Ruifen, Li, Siwen. 2024. Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma. In Journal of translational medicine, 22, 216. doi:10.1186/s12967-023-04700-8. https://pubmed.ncbi.nlm.nih.gov/38424632/
4. Han, Changjie, Jiao, Yan, Zhao, Qingguo, Lu, Baisong. 2014. Mex3c mutation reduces adiposity partially through increasing physical activity. In The Journal of endocrinology, 221, 457-68. doi:10.1530/JOE-14-0071. https://pubmed.ncbi.nlm.nih.gov/24741071/
5. Du, Yong, Sun, Dongjun, Li, Yan. . Mex3c mutation affects lactation through impairing milk ejection in female mice. In Bioscience reports, 40, . doi:10.1042/BSR20201285. https://pubmed.ncbi.nlm.nih.gov/33180120/
6. Kuniyoshi, Kanako, Takeuchi, Osamu, Pandey, Surya, Akira, Shizuo, Kawai, Taro. 2014. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. In Proceedings of the National Academy of Sciences of the United States of America, 111, 5646-51. doi:10.1073/pnas.1401674111. https://pubmed.ncbi.nlm.nih.gov/24706898/
7. Huang, Kejin, Liu, Dan, Su, Changlei. 2021. Circ_0007841 accelerates ovarian cancer development through facilitating MEX3C expression by restraining miR-151-3p activity. In Aging, 13, 12058-12066. doi:10.18632/aging.202911. https://pubmed.ncbi.nlm.nih.gov/33896797/
8. Yi, Hanjie, Han, Yongqing, Li, Qin, Xiong, Le, Li, Shanfeng. 2022. Circular RNA circ_0004488 Increases Cervical Cancer Paclitaxel Resistance via the miR-136/MEX3C Signaling Pathway. In Journal of oncology, 2022, 5435333. doi:10.1155/2022/5435333. https://pubmed.ncbi.nlm.nih.gov/36439901/